| [1] |
Downward J. RNA interference[J]. BMJ, 2004,328(7450): 1245-1248.
|
| [2] |
Napoli C, Lemieux C, Jorgensen R. Introduction of a chimeric chalcone synthase gene into petunia results in reversible cosuppression of homologous genes in trans [J]. Plant Cell,1990,2(4): 279-289.
|
| [3] |
Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans [J]. Nature,1998,391(6669): 806-811.
|
| [4] |
Steiner FA, Hoogstrate SW, Okihara KL, et al. Structural features of small RNA precursors determine Argonaute loading in Caenorhabditis elegans [J]. Nat Struct Mol Biol,2007,14(10): 927-933.
|
| [5] |
Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs [J]. Cell,2009,136(4): 642-655.
|
| [6] |
Masiero M, Nardo G, Indraccolo S, et al. RNA interference: implications for cancer treatment [J]. Mol Aspects Med,2007,28(1): 143-166.
|
| [7] |
Zhou D, He QS, Wang C, et al. RNA interference and potential applications [J]. Curr Top Med Chem,2006,6(9): 901-911.
|
| [8] |
Rual JF, Klitgord N, Achaz G. Novel insights into RNAi offtarget effects using C. elegans paralogs [J]. BMC Genomics,2007,8: 106.
|
| [9] |
Manjunath N, Dykxhoorn DM. Advances in synthetic siRNA delivery [J]. Discov Med,2010,9(48): 418-430.
|
| [10] |
Hannon GJ. RNA interference [J]. Nature, 2002,418(6894): 244-251.
|
| [11] |
Jiang Q, Zhang H, Zhang P. ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha,MMP-9,CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro [J]. J Exp Clin Cancer Res,2011,30: 60.
|
| [12] |
Li Y, Zhao L, Sun H, et al. Gene silencing of FANCF potentiates the sensitivity to mitoxantrone through activation of JNK and p38 signal pathways in breast cancer cells [J]. PLoS One,2012,7(8): e44254.
|
| [13] |
Zong X, Yang H, Yu Y, et al. Possible role of Pax-6 in promoting breast cancer cell proliferation and tumorigenesis[J]. BMB Rep,2011,44(9): 595-600.
|
| [14] |
Fang L, Shanqu L, Ping G, et al. Gene therapy with RNAi targeting UHRF1 driven by tumor-specific promoter inhibits tumor growth and enhances the sensitivity of chemotherapeutic drug in breast cancer in vitro and in vivo [J]. Cancer Chemother Pharmacol,2012,69(4): 1079-1087.
|
| [15] |
Li B, Chu X, Gao M, et al. The effects of CD59 gene as a target gene on breast cancer cells [J]. Cell Immunol, 2011,272(1): 61-70.
|
| [16] |
徐滨, 李媛媛, 张宝刚, 等. 小RNA 干扰降低COX-2 表达对乳腺癌细胞增殖和凋亡的影响[J]. 实用医学杂志,2011,27(22): 4018-1019.
|
| [17] |
Thorner AR, Parker JS, Hoadley KA, et al. Potential tumor suppressor role for the c-Myb oncogene in luminal breast cancer[J]. PLoS One,2010,5(10): e13073.
|
| [18] |
Han J, Zhang F, Yu M, et al. RNA interference-mediated silencing of NANOG reduces cell proliferation and induces G0/G1 cell cycle arrest in breast cancer cells[J]. Cancer Lett,2012,321(1): 80-88.
|
| [19] |
Daniel J, Coulter J, Woo JH, et al. High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells[J]. Proc Natl Acad Sci USA,2011,108(13): 5384-5389.
|
| [20] |
刘志祥,朱圣明,李瑞明,等. siRNA 沉默Chk1 基因对乳腺癌细胞MCF-7 增殖的影响及其作用机制的探讨[J]. 临床肿瘤学杂志,2012,17(6): 498-500.
|
| [21] |
Zhu Q, Jin L, Casero RA, et al. Role of ornithine decarboxylase in regulation of estrogen receptor alpha expression and growth in human breast cancer cells [J]. Breast Cancer Res Treat,2012,136(1): 57-66.
|
| [22] |
黄昱阳, 曹以诚, 祖冬梅. RNA 干扰对MDA-MB-231 细胞中CaSR 基因表达的影响[J]. 生物技术,2012,22(3): 51-55.
|
| [23] |
Yang Z, Cai JH, Xie SJ, et al. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice[J]. Chin Med J (Engl),2011,124(12): 1854-1861.
|
| [24] |
Sandhu R, Rivenbark AG, Coleman WB. Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3b[J].Breast Cancer Res Treat,2012,131(2): 385-399.
|
| [25] |
Wang J, Song Y, Xu S, et al. Down-regulation of ICBP90 contributes to doxorubicin resistance[J]. Eur J Pharmacol,2011,656(1/3): 33-38.
|
| [26] |
Liu JL, Wei W, Tang W, et al. Silencing of lysyl oxidase gene expression by RNA interference suppresses metastasis of breast cancer[J]. Asian Pac J Cancer Prev,2012,13(7): 3507-3511.
|
| [27] |
Guo D, Huang J, Gong J. Bone morphogenetic protein 4(BMP4) is required for migration and invasion of breast cancer[J]. Mol Cell Biochem,2012,363(1-2): 179-190.
|
| [28] |
熊向阳, 何宏银, 余乐涵,等. RNA 干扰抑制乙酰肝素酶的表达对乳腺癌细胞侵袭转移的影响[J]. 中国现代医学杂志,2012,22(16): 15-18.
|
| [29] |
Aagaard L, Rossi JJ. RNAi therapeutics: principles, prospects and challenges[J]. Adv Drug Deliv Rev,2007,59(2/3): 75-86.
|
| [30] |
Lambeth LS, Van Hateren NJ, Wilson SA, et al. A direct comparison of strategies for combinatorial RNA interference[J]. BMC Mol Biol,2010,11: 77.
|
| [31] |
Tschuch C, Schulz A, Pscherer A, et al. Off-target effects of siRNA specific for GFP[J]. BMC Mol Biol,2008,9: 60.
|
| [32] |
Martinez de Alba AE, Jauvion V, Mallory AC, et al. The miRNA pathway limits AGO1 availability during siRNAmediated PTGS defense against exogenous RNA[J]. Nucleic Acids Res,2011,39(21): 9339-9344.
|